Tumor-infiltrating lymphocytes and levels of PD-L1 and BRCA protein expression may identify patients with breast cancer with a higher rate of BRCA1 mutations.

Autor: Dimitrova, Polina Damyanova1, Popovska, Savelina Ljubenova1, Yordanov, Angel Danchev2 angel.jordanov@gmail.com
Zdroj: Nowotwory. 2022, Vol. 72 Issue 6, p355-364. 10p.
Databáze: Academic Search Ultimate